 | Zai Lab (ZLAB) Chairwoman & CEO Ying Du Sold $14.2 million of Shares
finance.yahoo.com - April 8 at 12:23 AM |
 | Zai Lab Limited (NASDAQ:ZLAB) CEO Sells $2,948,637.12 in Stock
americanbankingnews.com - April 7 at 10:46 PM |
| Insider Selling: Zai Lab Limited (NASDAQ:ZLAB) CEO Sells 50,784 Shares of Stock
americanbankingnews.com - April 7 at 10:46 PM |
| Zai Lab (NASDAQ:ZLAB) Shares Gap Up to $127.69
americanbankingnews.com - April 7 at 11:00 AM |
| Kai-Xian Chen Sells 4,302 Shares of Zai Lab Limited (NASDAQ:ZLAB) Stock
americanbankingnews.com - March 30 at 10:54 PM |
 | First Week of ZLAB May 21st Options Trading
nasdaq.com - March 22 at 2:01 PM |
| 7 Biotech Stocks With Catalysts That Go Far Beyond Covid-19 Vaccines
finance.yahoo.com - March 20 at 8:21 AM |
| Zai Lab is Now Oversold (ZLAB)
nasdaq.com - March 8 at 12:23 PM |
| Why Amgen's $1.9 Billion Takeover Might Only Whet Its Appetite In 2021
finance.yahoo.com - March 4 at 1:25 PM |
 | argenx Reports Full Year 2020 Financial Results and Provides Fourth Quarter Business Update
benzinga.com - March 4 at 1:59 AM |
|
| Analysts Are More Bearish On Zai Lab Limited (NASDAQ:ZLAB) Than They Used To Be
finance.yahoo.com - March 3 at 10:25 AM |
| Zai Lab Reaches Analyst Target Price
nasdaq.com - March 2 at 1:09 PM |
 | Zai Lab Limited 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 1 at 4:32 PM |
| Zai Lab Announces Financial Results for Second-half and Full-year 2020
finance.yahoo.com - March 1 at 9:48 AM |
 | Zai Lab earnings: here's what to expect
markets.businessinsider.com - February 28 at 11:25 PM |
 | ZLAB Mar 2021 165.000 call
uk.finance.yahoo.com - February 19 at 6:38 PM |
| Zai Lab to Announce Full-Year 2020 Financial Results on March 1, 2021
finance.yahoo.com - February 18 at 9:26 AM |
| ZLAB December 17th Options Begin Trading
nasdaq.com - January 19 at 6:13 PM |
| The ZLAB Paradox: Analysts Bullish But Forecast -23.94% Fall
nasdaq.com - January 11 at 9:13 AM |
| argenx and Zai Lab Announce Strategic Collaboration for Efgartigimod in Greater China
finance.yahoo.com - January 6 at 6:29 PM |
| Zai Lab Announces Inclusion of ZEJULA® (Niraparib) in China’s National Reimbursement Drug List
finance.yahoo.com - December 28 at 11:55 PM |
| Zai Lab Collaborates With Cullinan Oncology On CLN-081
nasdaq.com - December 28 at 8:54 AM |
| Zai Lab Partner MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic HER2-Positive Breast Cancer
finance.yahoo.com - December 16 at 10:08 PM |
| The ZLAB Paradox: Analysts Bullish But Forecast -1.45% Fall
nasdaq.com - December 7 at 4:48 PM |
| Zai Lab Appoints Alan Sandler, M.D., as President, Head of Global Development, Oncology
finance.yahoo.com - December 1 at 5:53 PM |
| Zai Lab Limited - American Depositary Shares
benzinga.com - November 28 at 10:57 PM |
| ZLAB Nov 2020 75.000 put
uk.finance.yahoo.com - November 24 at 9:59 AM |
| ZLAB Nov 2020 80.000 put
uk.finance.yahoo.com - November 23 at 6:29 PM |
| Zai Lab Announces First Patient Dosed in China in a Potentially Registrational Study of Retifanlimab in Patients with Endometrial Cancer
finance.yahoo.com - October 29 at 7:50 AM |
| Zai Lab Limited's (NASDAQ:ZLAB) Path To Profitability
finance.yahoo.com - October 28 at 7:38 PM |
| Zai Lab Announces Upcoming Presentations in November Investor Conferences
finance.yahoo.com - October 28 at 9:38 AM |
| Zai Lab Ltd. Reg. Shares (ADRs) (1ZL.SG)
ca.finance.yahoo.com - October 16 at 3:01 PM |
|
| Zai Lab Limited (1ZL.F)
in.finance.yahoo.com - October 13 at 1:21 PM |
| The Daily Biotech Pulse: FDA Panel Review For Alkermes, Axovant Gets Rare Pediatric Disease Designation, 2 IPOs
benzinga.com - October 9 at 7:22 AM |
| Zai Lab commences study in China testing margetuximab in stomach cancer
seekingalpha.com - October 6 at 9:25 AM |
| Zai Lab commences late-stage study of retifanlimab in lung cancer
seekingalpha.com - October 5 at 1:32 PM |
| Zai Lab Announces First Patient Dosed in China in a Global Phase 3 Study of Retifanlimab in Patients with NSCLC
markets.businessinsider.com - October 5 at 8:31 AM |
 | Zai Lab Announces Closing of Hong Kong Secondary Listing
marketwatch.com - September 28 at 12:16 PM |
| Zai Lab prices Hong Kong listing at HK$562
seekingalpha.com - September 22 at 8:53 AM |
| ZTO Express Raises $1.27 Billion in Hong Kong Listing
finance.yahoo.com - September 22 at 8:53 AM |
| Zai Lab Announces Pricing of Hong Kong Secondary Listing
finance.yahoo.com - September 22 at 8:53 AM |
| Week In Review: Zai Lab To Raise Up To $845 Million In Hong Kong IPO
seekingalpha.com - September 21 at 5:45 PM |
| Zai Lab's niraparib shows PFS benefit compared to placebo
seekingalpha.com - September 21 at 5:45 PM |
| Zai Lab' niraparib shows PFS benefit, compared to placebo
seekingalpha.com - September 21 at 12:44 PM |
| Phase 3 NORA data of ZEJULA® (niraparib) demonstrate significant PFS benefit, regardless of biomarker status, with an improved safety profile when given with individualized starting dose regimen in Chinese women with platinum-sensitive recurrent ovarian cancer
finance.yahoo.com - September 19 at 8:46 AM |
| Zai Lab Launches Hong Kong Secondary Listing
finance.yahoo.com - September 16 at 8:20 AM |
| Zai Lab's Zejula OK'd in China for first-line ovarian cancer
seekingalpha.com - September 10 at 10:37 PM |
| Zai Lab's Zeluja OK'd in China for first-line maintenance treatment of ovarian cancer
seekingalpha.com - September 10 at 12:35 PM |
| Can You Imagine How Jubilant Zai Lab's (NASDAQ:ZLAB) Shareholders Feel About Its 132% Share Price Gain?
finance.yahoo.com - September 10 at 12:35 PM |
| Can You Imagine How Jubilant Zai Lab's (NASDAQ:ZLAB) Shareholders Feel About Its 132% Share Price Gain?
finance.yahoo.com - September 10 at 12:35 PM |
